Subtype-specific effects of lithium on glutamate receptor function

Journal of Neurophysiology

Volumn 81, Issue 4, 1999, Pages 1506-1512

  Karkanias, Nikolas B ^a   Papke, Roger L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; CYCLOTHIAZIDE; GLUTAMATE RECEPTOR; KAINIC ACID; KAINIC ACID RECEPTOR; LITHIUM; RECEPTOR SUBTYPE; RUBIDIUM; SODIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; ION CURRENT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; VOLTAGE CLAMP; XENOPUS LAEVIS;

EID: 0033053129     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.1999.81.4.1506     Document Type: Article

References (16)

1. BARBOUR, B., KELLER, B. U., LLANO, I., AND MARTY, A. I. Prolonged presence of glutamate during excitatory synaptic transmission to cerebellar Purkinje cells. Neuron 12: 1331-1343, 1994.
2. BLISS, T.V.P. AND GARDNER-MEDWIN, A. R. Long-lasting potentiation of synaptic transmission in the dentate area of the unanaesthetized rabbit following stimulation of the perforant path. J. Physiol. (Lond.) 232: 357-374, 1973.
3. BLISS, T.V.P. AND LYNCH, M. A. Long-term potentiation of synaptic transmission in the hippocampus: properties and mechanisms. In: Long-term Potentiation: From Biophysics to Behavior. New York: Liss, 1988, p. 3-72.
4. COLLINGRIDGE, G. L. AND BLISS, T.V.P. NMDA receptors: their role in long-term potentiation. Trends Neurosci. 10: 288-293, 1987.
5. EBSTEIN, R. P., HERMONI, M., AND BELMAKER, R. H. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. J Pharmacol. Exp. Ther. 213: 161-167, 1980.
6. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252: 851-853, 1991.
7. KARKANIAS, N. B., KABAKOV, A. Y., LENOX, R. H., AND PAPKE, R. L. Synapse-specific accumulation of lithium in intracellular microdomains: a model for uncoupling coincidence detection in the brain. Synapse 28: 271-279, 1998.
8. LOMELI, H., MOSBACHER, J., MELCHER, T., HOGER, T., GEIGER, JR., KUNER, T., MONYER, H., HIGUCHI, M., BACH, A., AND SEEBURO, P. H. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 266: 1709-1713, 1994.
9. LUETJE, C. W. AND PATRICK, J. Both α-and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11: 837-845, 1991.
10. MONYER, H., SPRENGEL, R., SCHOEPFER, R., HERB, A., HIGUCHI, M., LOMELI, H., BURNASHEV, N., SAKMANN, B., AND SEEBURG, P. H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217-1221, 1992.
11. MOSBACHER, J., SCHOEPFER, R., MONYER, H., BURNASHEV, N., SEEBURG, P., AND RUPPERSBERG, J. A molecular determinant for submillisecond desensitization in glutamate receptors. Science 266: 1059-1062, 1994.
12. PARTIN, K. M., FLECK, M. W., AND MAYER, M. L. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J. Neurosci. 16: 6634-6647, 1996.
13. PARTIN, K. M., PATNEAU, D. K., WINTERS, C. A., MAYER, M. L., AND BUONANNO, A. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11: 1069-1082, 1993.
14. SOMMER, B., KEINÄNEN, K., VERDOORN, T. A., WISDEN, W., BURNASHEV, N., HERB, A., KOHLER, M., TAKAGI, T., SAKMANN, B., AND SEEBURG, P. H. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249: 1580-1585, 1990.
15. VYKLICKY, J. L., PATNEAU, D. K., AND MAYER, M. L. Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptors. Neuron 7: 971-984, 1991.
16. WONG, L. A. AND MAYER, M. L. Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-and kainate-preferring glutamate receptors. Mol. Pharmacol. 44: 504-510, 1993.